Precision BioSciences, Inc.
DTIL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $1 |
| % Growth | -27.8% | -37.9% | -95.5% | – |
| Cost of Goods Sold | $1 | $1 | $0 | $0 |
| Gross Profit | -$1 | -$1 | $0 | $1 |
| % Margin | -5,084.6% | -3,766.7% | 100% | 100% |
| R&D Expenses | $13 | $12 | $14 | $16 |
| G&A Expenses | $0 | $9 | $9 | $10 |
| SG&A Expenses | $7 | $9 | $9 | $10 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | $0 | $0 |
| Operating Expenses | $20 | $21 | $22 | $25 |
| Operating Income | -$21 | -$22 | -$22 | -$25 |
| % Margin | -158,976.9% | -121,538.9% | -76,248.3% | -3,894.4% |
| Other Income/Exp. Net | -$1 | -$2 | $2 | $7 |
| Pre-Tax Income | -$22 | -$24 | -$21 | -$18 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$22 | -$24 | -$21 | -$18 |
| % Margin | -167,476.9% | -130,666.7% | -70,913.8% | -2,781.3% |
| EPS | -1.842 | -2.13 | -2.3 | -2.51 |
| % Growth | 13.5% | 7.4% | 8.4% | – |
| EPS Diluted | -1.842 | -2.13 | -2.29 | -2.5 |
| Weighted Avg Shares Out | 12 | 11 | 9 | 7 |
| Weighted Avg Shares Out Dil | 12 | 11 | 9 | 7 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $1 | $1 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$21 | -$22 | -$20 | -$17 |
| % Margin | -159,507.7% | -124,811.1% | -67,262.1% | -2,601.3% |